Ebru KAVAK ÇELİK, Evrim GÜL, Salih Burçin KAVAK

Pregnancy and Peripartum Cardiomyopathy: Case Report

Peripartum cardiomyopathy is a rare but potentially life threating form of dilated cardiomyopathy of unknown etiology. Early diagnosis is important to decrease morbidity and mortality but delays in diagnosis are commonly observed because symptoms can be confused with physiological changes associated with advanced pregnancy. We herein report a case emerging in the postpartum period accompanied by preeclampsia and discuss the important issues in diagnosis and treatment.

PDF

___

Sharma K, Russell SD. An update on peripartum cardiomypathy in the 21st century. Int J Clin Cardiol. 2015;2:3

Mazor M. Idiopathic dilated cardiomyopathy in pregnancy. Arch Gynecol Obstet. 1994;255(1):51-3.

Cunningham FG, Pritchard JA, Hankins GD, Anderson PL, Lucas MJ, Armstrong KF. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events? Obstet Gynecol. 1986;67(2):157-68.

Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, RegitzZagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ; Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767-78.

Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T, Schrier RW. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54(6):2056-63.

Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27(4):441-6.

Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007;128(3):589-600.

Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ. 2006;332(7552):1251-5.

Lindenfeld J, Albert NM, Boehmer JP, Collins SP. Heart Failure Society of America, HFSA 2010. Compherensive heart failure practise guideline. J Card Fail. 2010:16;e1- 194.

Rasmusson KD, Stehlik J, Brown RN, Renlund DG, Wagoner LE, Torre-Amione G,Folsom JW, Silber DH, Kirklin JK; Cardiac Transplant Research Database Group. Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multi institutional analysis. J Heart Lung Transplant. 2007 ;26(11):1097-104.

Fett JD, Sannon H, Thélisma E, Sprunger T, Suresh V. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynaecol Obstet. 2009;104(2):125-7.

Honigberg MC, Givertz MM. Arrhythmias in peripartum cardiomyopathy. Card Electrophysiol Clin. 2015;7(2):309-17.

Kocak U, Tok D, Ipek G. Peripartum cardiomyopathy. Abant Med J. 2013;2(2):161-7.

Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol. 2008;199(4):415.e1-5.

Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, Becker A, Yip A, Klein G, Sliwa K. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10(9):861-8.